The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- October 2017
- DOI:
- 10.1371/journal.pone.0185940
- Bibcode:
- 2017PLoSO..1285940G